Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21336113rdf:typepubmed:Citationlld:pubmed
pubmed-article:21336113lifeskim:mentionsumls-concept:C0003175lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0038027lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0013604lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0805586lld:lifeskim
pubmed-article:21336113lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:21336113pubmed:issue6lld:pubmed
pubmed-article:21336113pubmed:dateCreated2011-5-25lld:pubmed
pubmed-article:21336113pubmed:abstractTextW1-mAb is a chimpanzee-derived monoclonal antibody to protective antigen that improved survival when administered before anthrax lethal toxin challenge in rats. To better define W1-mAb's efficacy for anthrax, we administered it after initiation of 24-hr infusions of edema toxin and lethal toxin either alone or together in rats or following anthrax spore challenge in mice.lld:pubmed
pubmed-article:21336113pubmed:languageenglld:pubmed
pubmed-article:21336113pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21336113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21336113pubmed:statusMEDLINElld:pubmed
pubmed-article:21336113pubmed:monthJunlld:pubmed
pubmed-article:21336113pubmed:issn1530-0293lld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:JupinIIlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:LiYanYlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:MoayeriMahtab...lld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:LepplaStephen...lld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:CuiXizhongXlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:EichackerPete...lld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:FitzYvonneYlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:ChenZhaochunZlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:JohnsonSydSlld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:PurcellRobert...lld:pubmed
pubmed-article:21336113pubmed:authorpubmed-author:AltaweelLaith...lld:pubmed
pubmed-article:21336113pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21336113pubmed:volume39lld:pubmed
pubmed-article:21336113pubmed:ownerNLMlld:pubmed
pubmed-article:21336113pubmed:authorsCompleteYlld:pubmed
pubmed-article:21336113pubmed:pagination1439-47lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:meshHeadingpubmed-meshheading:21336113...lld:pubmed
pubmed-article:21336113pubmed:year2011lld:pubmed
pubmed-article:21336113pubmed:articleTitleDelayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.lld:pubmed
pubmed-article:21336113pubmed:affiliationCritical Care Medicine Department, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.lld:pubmed
pubmed-article:21336113pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21336113pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed